EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling

HongDuck Yun iD, Ponmari Guruvaiya iD, Olena Levurdiak, Alexei G Basnakian iD, Marjan Boerma iD, Stephen Safe iD, KyoungHyun Kim iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27093886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von HongDuck Yun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72225, USA. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Histone Demethylases, Hedgehog Proteins, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, Arkansas Bioscience Institute, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with poor prognosis and limited therapeutic options. Although epigenetic dysregulation is a hallmark of HCC, rational combinatorial targeting strategies remain incompletely defined. Here, we identify cooperative oncogenic functions of the chromatin modifiers enhancer of zeste homolog 2 (EZH2) and lysine-specific demethylase 1 (LSD1) in HCC. Analysis of the TCGA-LIHC cohort revealed that co-elevated EZH2 and LSD1 expressions are significantly associated with reduced overall survival. Gene set enrichment analysis demonstrated enrichment of Sonic Hedgehog (SHH) signaling and stress-responsive transcriptional programs in tumors with high EZH2/LSD1 expression. Functionally, dual pharmacological inhibition of EZH2 (GSK126) and LSD1 (SP2509) suppressed HCC cell proliferation, induced G1-phase arrest, and enhanced apoptosis, as evidenced by increased caspase-3/7 activity and decreased pro-caspase levels. Dual inhibition also impaired migration, invasion, tumor sphere formation, and stemness-associated gene expression. Mechanistically, co-targeting disrupted SHH signaling through the suppression of GLI1 expression. Chromatin immunoprecipitation revealed reduced EZH2, LSD1, and STAT3 occupancy at the GLI1 promoter following dual inhibition, leading to the repression of GLI1 and its downstream targets. Collectively, these findings demonstrate that EZH2 and LSD1 cooperatively sustain GLI1-dependent SHH signaling in HCC, and that dual epigenetic inhibition represents a mechanistically defined therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinHistone DemethylasesHedgehog ProteinsLiver NeoplasmsCarcinoma, HepatocellularSignal TransductionHumansGene Expression Regulation, NeoplasticCell ProliferationCell Line, TumorZinc Finger Protein GLI1ApoptosisAnimalsThiophenesIndolesCell MovementHydrazinesPyridonesSulfonamides

Stichwörter der Autor:innen

EZH2GLI1LSD1SHHSTAT3dual inhibitionhepatocellular carcinoma

Substanzen

Enhancer of Zeste Homolog 2 ProteinHistone DemethylasesHedgehog ProteinsKDM1A protein, humanEZH2 protein, humanZinc Finger Protein GLI1SP2509SHH protein, humanThiophenesIndoles

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72225, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72225, USA.
  • Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.

ORCID-Profile: HongDuck Yun, Ponmari Guruvaiya, Alexei G Basnakian, Marjan Boerma, Stephen Safe, KyoungHyun Kim

Förderung

  • BLRD VA
  • Arkansas Bioscience Institute
  • NIGMS NIH HHS
  • Winthrop P. Rockefeller Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Yun, H., Guruvaiya, P., Levurdiak, O., Basnakian, A. G., Boerma, M., Safe, S., & Kim, K. (2026). Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27093886

Vancouver

Yun H, Guruvaiya P, Levurdiak O, Basnakian AG, Boerma M, Safe S, et al. Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27093886

BibTeX
@article{Yun2026,
  author = {Yun, HongDuck and Guruvaiya, Ponmari and Levurdiak, Olena and Basnakian, Alexei G and Boerma, Marjan and Safe, Stephen and Kim, KyoungHyun},
  title = {Dual Targeting of EZH2 and LSD1 Suppresses Hepatocellular Carcinoma via Disruption of Sonic Hedgehog Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27093886}
}
Kostenlos starten →